Depot medroxyprogesterone acetate (DMPA) are of a reduction in bone tissue mineral thickness (BMD) in females of various age groups. 1 Reassuringly, reports viewing lady over 40 which incorporate DMPA demonstrated that although users undertaking a preliminary reduction in BMD with usage, this isn’t recurring or worsened by menopause. 1 people over 40 with added possibilities issue for weakening of bones should give consideration to alternative methods.
Females over 40 which make use of DMPA for contraception needs to be evaluated on a regular basis to evaluate the pros and probability of continuing utilize. 1 regimen track of serum oestrogen level, lipids, or bone density isn’t presently ideal. For females aged 18a€“45 many years, DMPA is known as UKMEC classification 1; whereas for ladies aged over 45 decades, DMPA is recognized as UKMEC category 2. 2 For women aged over 50, the standard advises that women need informed to switch to an alternative solution technique. 1